rs35258119

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006308.3(HSPB3):​c.199G>A​(p.Gly67Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00124 in 1,614,094 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0070 ( 8 hom., cov: 32)
Exomes 𝑓: 0.00064 ( 11 hom. )

Consequence

HSPB3
NM_006308.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.951

Publications

1 publications found
Variant links:
Genes affected
HSPB3 (HGNC:5248): (heat shock protein family B (small) member 3) This gene encodes a muscle-specific small heat shock protein. A mutation in this gene is the cause of autosomal dominant distal hereditary motor neuropathy type 2C.[provided by RefSeq, Sep 2010]
HSPB3 Gene-Disease associations (from GenCC):
  • distal hereditary motor neuropathy type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neuronopathy, distal hereditary motor, type 2C
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043417215).
BP6
Variant 5-54455988-G-A is Benign according to our data. Variant chr5-54455988-G-A is described in ClinVar as Benign. ClinVar VariationId is 353898.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00703 (1070/152206) while in subpopulation AFR AF = 0.0234 (972/41532). AF 95% confidence interval is 0.0222. There are 8 homozygotes in GnomAd4. There are 526 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1070 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSPB3NM_006308.3 linkc.199G>A p.Gly67Ser missense_variant Exon 1 of 1 ENST00000302005.3 NP_006299.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSPB3ENST00000302005.3 linkc.199G>A p.Gly67Ser missense_variant Exon 1 of 1 6 NM_006308.3 ENSP00000303394.1

Frequencies

GnomAD3 genomes
AF:
0.00704
AC:
1070
AN:
152088
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0234
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00563
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00174
AC:
437
AN:
251096
AF XY:
0.00119
show subpopulations
Gnomad AFR exome
AF:
0.0237
Gnomad AMR exome
AF:
0.00121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000265
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000641
AC:
937
AN:
1461888
Hom.:
11
Cov.:
31
AF XY:
0.000498
AC XY:
362
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0225
AC:
754
AN:
33480
American (AMR)
AF:
0.00139
AC:
62
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000899
AC:
10
AN:
1112010
Other (OTH)
AF:
0.00171
AC:
103
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00703
AC:
1070
AN:
152206
Hom.:
8
Cov.:
32
AF XY:
0.00707
AC XY:
526
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.0234
AC:
972
AN:
41532
American (AMR)
AF:
0.00556
AC:
85
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68002
Other (OTH)
AF:
0.00427
AC:
9
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
53
106
158
211
264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00305
Hom.:
10
Bravo
AF:
0.00801
ESP6500AA
AF:
0.0204
AC:
90
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00222
AC:
269
Asia WGS
AF:
0.00115
AC:
5
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neuronopathy, distal hereditary motor, type 2C Benign:2
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
Apr 28, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
15
DANN
Benign
0.96
DEOGEN2
Benign
0.32
T
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.33
N
LIST_S2
Benign
0.52
T
MetaRNN
Benign
0.0043
T
MetaSVM
Benign
-0.61
T
MutationAssessor
Benign
0.070
N
PhyloP100
0.95
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.53
N
REVEL
Benign
0.10
Sift
Benign
0.16
T
Sift4G
Benign
0.47
T
Polyphen
0.036
B
Vest4
0.077
MVP
0.69
MPC
0.092
ClinPred
0.0028
T
GERP RS
2.1
PromoterAI
-0.020
Neutral
Varity_R
0.077
gMVP
0.29
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35258119; hg19: chr5-53751818; API